Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to realise the long-term curative benefits of immunotherapy for more patients by devising new treatments, broadening the impact of existing treatments, and reducing side effects.
Immuno-oncology

Through the Oxford Cancer Immuno-Oncology Network (OCION), we aim to realise the long-term curative benefits of immunotherapy for more patients by devising new treatments, broadening the impact of existing treatments, and reducing side effects.

Through the Oxford Centre for Early Cancer Detection (OxCODE), we are addressing the target in NHS England’s Long Term Plan to detect 75% of cancers at an early stage by 2028.
Early Cancer Detection

Through the Oxford Centre for Early Cancer Detection (OxCODE), we are addressing the target in NHS England’s Long Term Plan to detect 75% of cancers at an early stage by 2028.

Through the analysis of large, complex data sets, we can improve the patient experience by predicting and detecting cancer earlier, developing new treatments or optimising existing ones
Cancer Big Data

Through the analysis of large, complex data sets, we can improve the patient experience by predicting and detecting cancer earlier, developing new treatments or optimising existing ones

By developing new therapies and improving the utilisation of existing ones, Oxford researchers are improving the outcomes for cancer patients worldwide
Novel Therapeutics

By developing new therapies and improving the utilisation of existing ones, Oxford researchers are improving the outcomes for cancer patients worldwide

Oxford is home to over 60 research groups focusing on data science and its application to cancer research. Ranging from electronic patient record epidemiology and health-economic assessment, to computer vision, modelling and molecular informatics
Data Science

Oxford is home to over 60 research groups focusing on data science and its application to cancer research. Ranging from electronic patient record epidemiology and health-economic assessment, to computer vision, modelling and molecular informatics

Oxford has over 150 research groups across the city specialising in molecular, cellular, tissue and tissue-level processes that underpin health, disease and all life as we know it
Cell Biology & Tissue Physiology

Oxford has over 150 research groups across the city specialising in molecular, cellular, tissue and tissue-level processes that underpin health, disease and all life as we know it

Oxford is ranked top in Europe for immunology research and is home to 85 research groups seeking to build on this standard of excellence and apply it to all aspect of our understanding of cancer
Immunology

Oxford is ranked top in Europe for immunology research and is home to 85 research groups seeking to build on this standard of excellence and apply it to all aspect of our understanding of cancer

Based across the city of Oxford, researchers are developing cutting-edge technologies that integrate analytical and engineering science, to better treat and diagnose cancer patients
Physical Sciences & Drug Discovery

Based across the city of Oxford, researchers are developing cutting-edge technologies that integrate analytical and engineering science, to better treat and diagnose cancer patients

A global health project, bringing next generation technologies to Tanzania and Uganda, and improving the in-country testing process for EBV lymphomas.
AI-REAL

A global health project, bringing next generation technologies to Tanzania and Uganda, and improving the in-country testing process for EBV lymphomas.

A follow-on clinical trial investigating antimalarial drug Atovaquone as a method to improve the impact of chemoradiotherapy
ARCADIAN

A follow-on clinical trial investigating antimalarial drug Atovaquone as a method to improve the impact of chemoradiotherapy

Using data collected by the NHS Lung Health Check programme to develop and validate Artificial Intelligence to more accurately and quickly diagnose lung disease
DART

Using data collected by the NHS Lung Health Check programme to develop and validate Artificial Intelligence to more accurately and quickly diagnose lung disease

A research study into methods of early detection of hepatocellular liver cancer, using novel blood tests, imaging technologies and next generation sequencing to identify new biomarkers and underlying mechanisms that can lead to cancer progression
DeLIVER

A research study into methods of early detection of hepatocellular liver cancer, using novel blood tests, imaging technologies and next generation sequencing to identify new biomarkers and underlying mechanisms that can lead to cancer progression

A multi-disciplinary clinical trial and research project investigating new immunotherapy drug opportunities in oesophageal cancer.
LUD2015-005

A multi-disciplinary clinical trial and research project investigating new immunotherapy drug opportunities in oesophageal cancer.

A novel cancer immunotherapy vaccine based on new & unique surface molecules that Oxford researchers have discovered.
MAGE Cancer Vaccine (VTP-600)

A novel cancer immunotherapy vaccine based on new & unique surface molecules that Oxford researchers have discovered.

An observational cohort study to identify early detection markers for malignant blood cancers such as CLL and MGUS
OxPLoreD

An observational cohort study to identify early detection markers for malignant blood cancers such as CLL and MGUS

Developing novel drug delivery systems using ultrasound, capable of enhancing drug penetration into and around a tumour, whilst minimising patient toxicity.
PanDox

Developing novel drug delivery systems using ultrasound, capable of enhancing drug penetration into and around a tumour, whilst minimising patient toxicity.

The award-winning Suspected Cancer Pathway designed to accelerate cancer diagnoses in patients with non-specific symptoms, now being implemented nationally and underpinning several research projects.
SCAN

The award-winning Suspected Cancer Pathway designed to accelerate cancer diagnoses in patients with non-specific symptoms, now being implemented nationally and underpinning several research projects.

The SYMPLIFY study will evaluate the revolutionary multi-cancer blood test Galleri, for future implementation in the NHS.
SYMPLIFY

The SYMPLIFY study will evaluate the revolutionary multi-cancer blood test Galleri, for future implementation in the NHS.

Improving early detection of cancer through novel liquid-biopsy based diagnostic tests, that are specific and sensitive enough to test for a variety of cancers.
TAPS Technology

Improving early detection of cancer through novel liquid-biopsy based diagnostic tests, that are specific and sensitive enough to test for a variety of cancers.

A prospective study using the largest data-base of its kind, collecting information on new potential risk factors for women and ultimately informing public health policies
The Million Women Study

A prospective study using the largest data-base of its kind, collecting information on new potential risk factors for women and ultimately informing public health policies

‘COMBATcancer’ (Combined Molecular Analysis of Blood and Tissue in cancer) is a programme initiated by the CRUK Oxford Centre in 2023.
COMBATcancer

‘COMBATcancer’ (Combined Molecular Analysis of Blood and Tissue in cancer) is a programme initiated by the CRUK Oxford Centre in 2023.

OxCITE (Oxford Cancer Immunotherapy Toxicity and Efficacy) is a cohort study initiated in November 2015 with samples collected within the Oxford Radcliffe Biobank. It explores the relationships between patients’ genetics, immune systems, and response to checkpoint immunotherapy.
OxCITE

OxCITE (Oxford Cancer Immunotherapy Toxicity and Efficacy) is a cohort study initiated in November 2015 with samples collected within the Oxford Radcliffe Biobank. It explores the relationships between patients’ genetics, immune systems, and response to checkpoint immunotherapy.

Oxford's Pancreatic Network
PancrImmune

Oxford's Pancreatic Network

The international partnership for developing a gastrointestinal cancer plan
Sichuan University (West China Hospital)-Oxford University Gastrointestinal Cancer Centre

The international partnership for developing a gastrointestinal cancer plan

Stratification in Colorectal Cancer
S:CORT

Stratification in Colorectal Cancer

Oxford's Colorectal Cancer Stratified Medicine Network
ACRCelerate

Oxford's Colorectal Cancer Stratified Medicine Network

Advanced Radiotherapy Technologies Network
ART-NET

Advanced Radiotherapy Technologies Network

Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer
EHNBPCCG

Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer

Improving Immunotherapy treatment for cancer patients
Southampton Immune Accelerator

Improving Immunotherapy treatment for cancer patients

Driving innovation in the use of artificial intelligence (AI) for improved diagnosis and treatment in cancer
National Consortium for Intelligent Medical Imaging (NCIMI)

Driving innovation in the use of artificial intelligence (AI) for improved diagnosis and treatment in cancer

Pathology image data Lake for Education, Analytics and Discovery
PathLAKE

Pathology image data Lake for Education, Analytics and Discovery

A network of medical imaging experts working towards discovery, validation and adoption of cancer imaging biomarkers
National Cancer Imaging Translational Accelerator (NCITA)

A network of medical imaging experts working towards discovery, validation and adoption of cancer imaging biomarkers

In establishing our Oesophageal Cancer Centre of Excellence, we have cultivated an Oxford-based community of clinicians to take the field forward.
Oesophagogastric Cancer Centre of Excellence

In establishing our Oesophageal Cancer Centre of Excellence, we have cultivated an Oxford-based community of clinicians to take the field forward.

The Liver Cancer Centre of Excellence leverages Oxford’s internationally renewed multi-disciplinary cancer expertise and world-class data science prowess to accelerate the translation of liver cancer research into the clinic.
Liver Cancer Centre of Excellence

The Liver Cancer Centre of Excellence leverages Oxford’s internationally renewed multi-disciplinary cancer expertise and world-class data science prowess to accelerate the translation of liver cancer research into the clinic.

The Oxford Cancer Vaccine Hub facilitates innovation from multiple research groups and aims to achieve transformative benefits in the treatment of multiple cancer types, as well as preventing cancer development/recurrence in people at clinically defined higher risk.
Oxford Cancer Vaccine Hub

The Oxford Cancer Vaccine Hub facilitates innovation from multiple research groups and aims to achieve transformative benefits in the treatment of multiple cancer types, as well as preventing cancer development/recurrence in people at clinically defined higher risk.